| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Interim CFO, Prin Acct Officer | Principal Accounting Officer
1 company
Sean Michael Smith last filed a Form 4 in August 2023, as Interim CFO, Prin Acct Officer at NGNE. Sean Michael Smith's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Sean Michael Smith a below-average insider score of 32/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -54.8%.
At the last filing, the largest reported position was 21,637 shares of NGNE. The NGNE filings lean toward selling, a net 6,294 shares.
Sean Michael Smith has 5 Form 4 filings on record from March 2022 to August 2023, all as Interim CFO, Prin Acct Officer at Neurogene (NGNE), 2022–2023.
The 8 reported transactions were 3 option exercises, 3 open-market sales and 2 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $4K.
The largest open-market sale was 3,316 shares of NGNE at an average $0.60 on February 2, 2023, about $2K. Twelve months later NGNE was up 168%.
Shares as reported in the last Form 4 for each company; the most recent is from August 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | NGNE Neurogene Inc. | Interim CFO, Prin Acct Officer | Sale+OE | 1,323 | $0.62 | $818.14 | -5.8% | +8.1% | +187.0% | |
| Feb 2, 2023 | NGNE Neurogene Inc. | Principal Accounting Officer | Sale+OE | 3,316 | $0.60 | $1,980.32 | -17.2% | +52.2% | +167.8% | |
| Aug 10, 2022 | NGNE Neurogene Inc. | Principal Accounting Officer | Sale+OE | 1,655 | $0.99 | $1,640.77 | -19.6% | -46.3% | -35.7% |